The insider sales are too small relative to market cap to warrant a bearish read. Monitor for any material corporate events (e.g., earnings, pipeline updates) that could explain the timing, but no immediate action is needed.
EXEL drugs
EXEL drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · May 29 $50.32entry
- T+1 · 6mo ago −0.08%α −0.35% · $50.28
- T+5 · 6mo ago +2.55%α +2.84% · $51.60
- T+20 · 5mo ago +8.85%α +12.48% · $54.77
- T+60 · 3mo ago +8.17%α +7.24% · $54.43
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two EVPs at Exelixis sold a combined $3.79M in open-market sales over a week, while seven directors received non-cash stock grants. The sales represent ~0.03% of market cap, which is trivial relative to the $12.9B company. The cluster is driven by C-suite selling, but the dollar amount is immaterial and likely reflects routine portfolio diversification rather than a bearish signal.
Key Financial Metrics
Key Facts
- EVP Patrick J. Haley sold 32,100 shares at $49.81 for $1.60M on 2026-05-20
- EVP Dana Aftab sold 43,451 shares at $50.35 for $2.19M on 2026-05-26
- Seven directors received non-cash stock grants totaling 69,335 shares at $0 on 2026-05-27
- Total open-market sales of $3.79M represent ~0.03% of Exelixis's $12.9B market cap
- No insider open-market purchases were reported in the cluster
Financial Impact
Open-market sales of $3.79M, or ~0.03% of market cap, immaterial
Risk Factors
- C-suite selling could indicate private concerns not yet public, though dollar amount is trivial
- No insider buying to offset the selling signal
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-EXEL-1780091011818 |
Track record
16 reports on EXEL
0 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +21.97% at T+60 after the Feb 28, 2026 report. 1 of 3 went positive at some point.
Filters
- Nov 9, 20267d ago SC 13G Neutral 3/10 Entry $70.58 to $70.70 Now $67.10 −4.93% ▲ +0.17% −1.15% vs SPY
- Nov 9, 20267d ago SC 13D/A Bearish 5/10 Entry $70.58 to $70.70 Now $67.10 +4.93% ▼ −0.17% +1.15% vs SPY
- Oct 29, 202618d ago 8-K Neutral 5/10 Entry $69.39 to $70.13 Now $67.10 −3.30% ▲ +1.07% +1.55% vs SPY
- Oct 20, 202627d ago Institutional Cluster Neutral 2/10 Entry $64.58 to $65.31 Now $67.10 +3.90% ▲ +1.13% +2.31% vs SPY
- Oct 12, 20265w ago Institutional Cluster Neutral 3/10 Entry $59.82 to $59.51 Now $67.10 +12.17% ▼ −0.52% −0.51% vs SPY
- Sep 11, 20269w ago 8-K Bearish 6/10 Entry $56.12 to $56.21 Now $67.10 −19.57% ▼ −0.16% −0.61% vs SPY
- Jun 3, 202623w ago Insider Cluster Neutral 2/10 Entry $52.39 to $52.69 Now $67.10 +28.08% ▲ +0.57% +3.17% vs SPY
- May 29, 202624w ago 8-K Neutral 3/10 Entry $50.20 to $48.49 Now $67.10 +33.67% ▼ −3.41% −3.55% vs SPY
- May 28, 202624w ago Insider Cluster Neutral 3/10 Viewing Entry $50.32 to $50.28 Now $67.10 +33.35% ▼ −0.08% −0.35% vs SPY
- May 28, 202624w ago Insider Cluster Neutral 3/10 Entry $50.32 to $50.28 Now $67.10 +33.35% ▼ −0.08% −0.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers